Vida Demarin (International Institute for Brain Health, Zagreb, Croatia) kindly took the time to speak with us on the topic of the debate session she participated in: Should statins be given to people over age 80 for stroke prevention? As co-Chair of CONy 2021, she also shared her excitement for the next congress, which will be hosted in Dubrovnik, in her home country, Croatia.
- What risks are associated with long-term statin use, and how do these risks change with age? (0:06)
- What clinical data are available to assess the benefits and risks of statins in people aged over 80 for stroke prevention? (1:31)
- What are the potential issues with extrapolating data from studies involving younger patients? (2:55)
- In your opinion, should statins be given to over 80s for stroke prevention? (4:16)
- How can we improve our evidence base for this indication? (5:56)
Support: Interview and filming supported by Touch Medical Media Ltd.
Disclosures: Vida Demarin has nothing to disclose in relation to this video.
Filmed in coverage of the 14th World Congress on Controversies in Neurology (CONy Virtual, November 2020).
Share this Video
Related Videos In Stroke
Hariklia Proios, Stroke Alliance for Europe (SAFE): Presidential Update
The Stroke Alliance for Europe (SAFE) is a non-profit-making organisation that represents a range of patient groups from across Europe. Their mutual goal is to drive stroke prevention up the European political agenda and prevent the incidence of stroke through education. touchNEUROLOGY caught up with the SAFE President, Prof. Hariklia (Harriet) Proios, to discuss the […]
Martin Bretzner, ESOC 2022: Brain-age biomarkers to predict post-stroke recovery
Brain-age biomarkers can be used to predict post-stroke recovery. Dr Martin Bretzner (Lille Neuroscience & Cognition Research Centre, Lille University Hospital, Lille, France) discusses the results of a study using radiomics, an emerging image-quantifying technology to assess ‘brain-age’ biomarkers. The study investigates how relative brain age, rather than chronological age, can enhance stroke surveillance and […]
Miquel Lledós, ESOC 2022: The influence of gut microbiome on ischaemic stroke risk and outcome
The composition of the gut microbiome is a modifiable factor associated with the risk of ischaemic stroke and post-stroke neurological outcome. Dr Miquel Lledós (Stroke Pharmacogenomics and Genetics Laboratory, Sant Pau Research Institute, Barcelona, Spain) discusses the outcome of a study using faecal samples to demonstrate the influence of the gut microbiome on ischaemic stroke […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!